Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 7Not yet recruiting 2Completed 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 549Neoplasms 384Carcinoma, Non-Small-Cell Lung 319Colorectal Neoplasms 290Lung Neoplasms 239Prostatic Neoplasms 219Carcinoma, Hepatocellular 212Stomach Neoplasms 158Pancreatic Neoplasms 151Leukemia, Myeloid, Acute 139Multiple Myeloma 130Uterine Cervical Neoplasms 127Recurrence 116Rectal Neoplasms 112Ovarian Neoplasms 105Neoplasm Metastasis 104Squamous Cell Carcinoma of Head and Neck 97Head and Neck Neoplasms 89Esophageal Neoplasms 85Triple Negative Breast Neoplasms 84Glioblastoma 80Small Cell Lung Carcinoma 79Endometrial Neoplasms 79Colonic Neoplasms 78Brain Neoplasms 78Melanoma 69Precursor Cell Lymphoblastic Leukemia-Lymphoma 66Hematologic Neoplasms 64Glioma 62Motor Activity 60

Interventions

dostarlimab 1XELOX 1Oxaliplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Locally Advanced Rectal Cancer (LARC) × Clear all
NCT07581626 2026-05-18

Short-Course Online Adaptive Radiotherapy Combined With Chemotherapy, Targeted Therapy and Immunotherapy as Total Neoadjuvant Therapy (TNT) for Locally Advanced Rectal Cancer

Chinese PLA General Hospital

Phase 2 Not yet recruiting
60 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

NCT07381777 2026-02-02

IMMUNOSTAR

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 2 Not yet recruiting
270 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡